Cite
Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer.
MLA
Du, Yan, et al. “Discovery and Validation of Circulating EVL MRNA as a Prognostic Biomarker in Pancreatic Cancer.” Journal of Oncology, Apr. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1155/2021/6656337.
APA
Du, Y., Yao, K., Feng, Q., Mao, F., Xin, Z., Xu, P., & Yao, J. (2021). Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer. Journal of Oncology, 1–11. https://doi.org/10.1155/2021/6656337
Chicago
Du, Yan, Kai Yao, Qingbo Feng, Feiyu Mao, Zechang Xin, Peng Xu, and Jie Yao. 2021. “Discovery and Validation of Circulating EVL MRNA as a Prognostic Biomarker in Pancreatic Cancer.” Journal of Oncology, April, 1–11. doi:10.1155/2021/6656337.